menu
    • menu

    Company profile for InvaGen Pharmaceuticals Inc

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InvaGen Pharmaceuticals, Inc., with Corporate Head Quarters in Hauppauge, New York is a leading generic pharmaceutical company. InvaGen is engaged in Development, Manufacturing, Marketing and Distributing in generic pharmaceuticals with focus on wide range of therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants. Dosage forms include both immediate release and m...
    InvaGen Pharmaceuticals, Inc., with Corporate Head Quarters in Hauppauge, New York is a leading generic pharmaceutical company. InvaGen is engaged in Development, Manufacturing, Marketing and Distributing in generic pharmaceuticals with focus on wide range of therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants. Dosage forms include both immediate release and modified release and extended release of tablets and capsules. InvaGen has facility with over 125,000 sq.ft. manufacturing and laboratory area with over 400 employees specialized in different fields. InvaGen’s goal is to come up with innovations in generic medicines, improved quality of life for patients from high quality cost effective medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InvaGen Pharmaceuticals IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7 Oser Avenue ,Hauppauge, NY 11788
    Telephone
    Telephone
    631 231 3233
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.invagen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Invagen Pharms’ Generics Rivaroxaban Receives Approval in US
    Invagen Pharms’ Generics Rivaroxaban Receives Approval in US

    20 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218768

    FDA
    20 Feb 2026
    Share Share
    Bora Biologics Partners With Invagen Pharma To Produce
    Bora Biologics Partners With Invagen Pharma To Produce

    25 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bora-biologics-to-manufacture-nypozitm-at-san-diego-facility-in-partnership-with-inva-1078073

    ACCESSWIRE
    25 Sep 2025
    Share Share
    InvaGen`s Generics Rivaroxaban Receives Approval in US
    InvaGen`s Generics Rivaroxaban Receives Approval in US

    14 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208555

    FDA
    14 May 2025
    Share Share
    Invagen Pharms`s Generics Linagliptin Receives Approval in US
    Invagen Pharms`s Generics Linagliptin Receives Approval in US

    03 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208423

    FDA
    03 Sep 2024
    Share Share
    InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets
    InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets

    18 Dec 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/invagen-pharmaceuticals-issues-voluntary-nationwide-recall-vigabatrin-oral-solution-usp-500mg-due

    FDA
    18 Dec 2023
    Share Share
    Cipla unit recalls anti-seizure drug because of faulty packaging
    Cipla unit recalls anti-seizure drug because of faulty packaging

    12 Dec 2023

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/cipla-unit-recalls-one-lot-anti-seizure-drug-due-packaging-problem

    Joseph Keenan FIERCE PHARMA
    12 Dec 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search